ScandiBio Therapeutics AB
ScandiBio Therapeutics is dedicated to developing innovative metabolic co-factors and integrating systems biology and artificial intelligence to treat metabolic diseases. Their mission involves understanding host-microbiome interactions and applying advanced technology and science to develop effective treatment strategies for conditions like NAFLD, COVID-19, and neurological diseases.
Industries
biotechnology
health-care
Nr. of Employees
small (1-50)